Financhill
Back

Novo Nordisk AS Quote, Financials, Valuation and Earnings

Novo Nordisk AS Price Quote

$135.18
-1.30 (-0.95%)
(Updated: September 16, 2024 at 4:00 PM ET)

Novo Nordisk AS Key Stats

Sell
46
Novo Nordisk AS (NONOF) is a Sell

Day range:
$133.76 - $137.71
52-week range:
$86.75 - $149.55
Dividend yield:
1.06%
P/E ratio:
50.48
P/S ratio:
16.32
P/B ratio:
37.61%

Volume:
14K
Avg. volume:
24.8K
1-year change:
38.7%
Market cap:
$607.6B
Revenue:
$33.7B
EPS:
$2.91

How Much Does Novo Nordisk AS Make?

Is Novo Nordisk AS Growing As A Company?

  • What Is Novo Nordisk AS's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.24%
  • What Is Novo Nordisk AS's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.03%

Novo Nordisk AS Stock Price Performance

  • Did Novo Nordisk AS Stock Go Up Last Month?
    Novo Nordisk AS share price went up by 2.01% last month
  • Did NONOF's Share Price Rise Over The Last Year?
    NONOF share price rose by 38.7% over the past 1 year

What Is Novo Nordisk AS 52-Week High & Low?

Novo Nordisk AS Price To Free Cash Flow

Is It Risky To Buy Novo Nordisk AS?

  • How Much Debt Does Novo Nordisk AS Have?
    Total long term debt quarterly is $8.2B
  • How Much Cash Does Novo Nordisk AS Have?
    Cash and short term investments quarterly total is $9B
  • What Is Novo Nordisk AS’s Book Value Per Share?
    Book value per share is 3.63

Is Novo Nordisk AS Cash Flow Positive?

  • What Is NONOF Cash Flow From Operations?
    Cash flow from operations (TTM) is $16.6B
  • What Is Novo Nordisk AS’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$5.7B
  • What Is Novo Nordisk AS’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.5B

Novo Nordisk AS Return On Invested Capital

  • Is Management Doing A Good Job?
    NONOF return on invested capital is 68.37%
  • What Is Novo Nordisk AS Return On Assets?
    ROA measures how assets are converting to revenues and is 28.81%
  • What Is NONOF Return On Equity?
    ROE is a measure of profitability and is 89.79%

Novo Nordisk AS Earnings Date & Stock Price

Novo Nordisk AS Competitors

Novo Nordisk AS Dividend Yield

Novo Nordisk AS Analyst Estimates

YoY Growth Past Surprise
EPS: 2.65% 0%
Revenue: 23.79% -0.96%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 95.19
Downside from Last Price: -30.25%

Major Shareholders

  • How many NONOF shares are owned by institutional investors?
    786.4M NONOF shares are owned by institutional investors
  • How many NONOF shares are owned by insiders?
    0 NONOF shares are owned by insiders